MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Multiple system atrophy(MSA): Clinical features"

  • 2023 International Congress

    Prevalence of multiple system atrophy in Europe: literature review

    S. Kaplan (Netanya, Israel)

    Objective: To provide a literature overview on the prevalence of multiple system atrophy (MSA) in selected European countries Background: Multiple system atrophy (MSA) is a…
  • 2023 International Congress

    Heterozygous aprataxin gene mutation associated with atypical multiple system atrophy phenotype: a case report

    A. Imarisio, A. Pilotto, A. Lupini, G. Biasiotto, I. Zanella, I. Palmieri, EM. Valente, A. Padovani (Pavia, Italy)

    Objective: We describe a 73-year old patient carrying a heterozygous mutation in aprataxin (APTX) gene presenting multiple system atrophy-parkinsonian variant (MSA-P). Background: Ataxia with oculomotor…
  • 2023 International Congress

    UMSARS versus laryngoscopy-based assessment of dysphagia

    N. El Fassi, A. Pavy-Le-Traon, E. Mouchon, O. Rascol, W. Meissner, A. Foubert-Saumier, Y. Gallois, S. Tessier, F. Ory-Magne, V. Woizard, M. Fabbri (Toulouse, France)

    Objective: To compare the Unified Multiple System Atrophy Rating Scale (UMSARS)   part I-item 2 with an ear/nose/throat (ENT) expert physician assessment. Background: Early and severe…
  • 2023 International Congress

    Clinical and radiological characteristics of a cohort of seventy-one Multiple System Atrophy patients

    G. Franco, G. Lazzeri, E. Bernardi, F. Arienti, A. Di Fonzo (Milan, Italy)

    Objective: This study aimed to review the characteristics of large cohort of MSA patients diagnosis in our center, confirming previous clinical and imaging data from…
  • 2023 International Congress

    Use and Misuse of the Unified Multiple System Atrophy Rating Scale

    A. Ferreirós, S. Castillo-Torres, M. Merello (Buenos Aires, Argentina)

    Objective: To quantify the use and variation of the motor part of Unified Multiple System Rating Scale (UMSARS II) on prospectively planned studies. Background: Despite…
  • 2023 International Congress

    An atypical presentation of Multiple System Atrophy (MSA)

    M. Magriço, V. Ferreira, B. Meira, R. Barbosa, P. Bugalho (Lisboa, Portugal)

    Objective: To discuss the etiological differential diagnosis of the clinical phenotype characterized by myoclonus and parkinsonism. Background: The presence of myoclonus is increasingly recognized as…
  • 2023 International Congress

    Correlation between Motor Sections of UMSARS and MDS-UPDRS

    S. Castillo-Torres, A. Ferreirós, M. Merello (Buenos Aires, Argentina)

    Objective: To determine the correlation between UMSARS II and MDS-UPDRS III. Background: Despite the availability of the Unified Multiple System Atrophy Rating Scale (UMSARS) [1]…
  • 2023 International Congress

    A multimodal approach for diagnosis of early Multiple System Atrophy (MSA)

    D. Claassen, J. Iregui, P. Trujillo, A. Wynn, C. Wong, M. Bradbury, D. Stamler (Nashville, USA)

    Objective: To describe the use of neuroimaging and fluid biomarkers to improve the diagnostic accuracy of early MSA. Background: The diagnosis of early MSA is…
  • 2023 International Congress

    Investigation of usefulness of new MSA diagnostic criteria

    M. Tarisawa, M. Matsushima, A. Kudo, K. Sakushima, Y. Kanatani, N. Nishimoto, J. Sawada, T. Matsuoka, S. Hisahara, H. Uesugi, N. Minami, K. Sako, A. Takei, A. Tamakoshi, N. Sato, H. Sasaki, I. Yabe (Sapporo, Japan)

    Objective: We investigated the utility of the Movement Disorder Society Criteria (MDS criteria) including sensitivity and specificity. Background: Multiple system atrophy (MSA) is an adult-onset…
  • 2023 International Congress

    Data-driven subtypes of multiple system atrophy and the implication on prognosis

    C-C. Fan, C. Han, X-M. Wang, W. Mao, E-H. Xu, P. Chan, S-Y. Liu (Beijing, China)

    Objective: To determine the clinical subtypes of MSA using data-driven approach and to compare the differences of the subtypes on survival and bed-ridden rates. Background:…
  • « Previous Page
  • 1
  • …
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 23
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Welcome to the MDS Abstracts Site
  • Effect of marijuana on Essential Tremor: A case report
  • Advanced Search
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley